ABP-450

· AEON Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABP-450, covering 2024-02-14 to 2024-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention [Phase 2]

See pricing